These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 22499728)

  • 41. The Net Reclassification Index (NRI): a Misleading Measure of Prediction Improvement Even with Independent Test Data Sets.
    Pepe MS; Fan J; Feng Z; Gerds T; Hilden J
    Stat Biosci; 2015 Oct; 7(2):282-295. PubMed ID: 26504496
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evaluation of markers and risk prediction models: overview of relationships between NRI and decision-analytic measures.
    Van Calster B; Vickers AJ; Pencina MJ; Baker SG; Timmerman D; Steyerberg EW
    Med Decis Making; 2013 May; 33(4):490-501. PubMed ID: 23313931
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Statistical inference for decision curve analysis, with applications to cataract diagnosis.
    Sande SZ; Li J; D'Agostino R; Yin Wong T; Cheng CY
    Stat Med; 2020 Sep; 39(22):2980-3002. PubMed ID: 32667093
    [TBL] [Abstract][Full Text] [Related]  

  • 44. On the validity of time-dependent AUC estimators.
    Schmid M; Kestler HA; Potapov S
    Brief Bioinform; 2015 Jan; 16(1):153-68. PubMed ID: 24036698
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Predictive biomarkers for treatment selection: statistical considerations.
    Chen JJ; Lu TP; Chen YC; Lin WJ
    Biomark Med; 2015; 9(11):1121-35. PubMed ID: 26507127
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Metrics for Evaluating Polygenic Risk Scores.
    Baker SG
    JNCI Cancer Spectr; 2021 Feb; 5(1):. PubMed ID: 34957374
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Statistical methods for evaluating DNA methylation as a marker for early detection or prognosis.
    Alonzo TA; Siegmund KD
    Dis Markers; 2007; 23(1-2):113-20. PubMed ID: 17325431
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Using relative utility curves to evaluate risk prediction.
    Baker SG; Cook NR; Vickers A; Kramer BS
    J R Stat Soc Ser A Stat Soc; 2009 Oct; 172(4):729-748. PubMed ID: 20069131
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Decision curve analysis: a technical note.
    Zhang Z; Rousson V; Lee WC; Ferdynus C; Chen M; Qian X; Guo Y;
    Ann Transl Med; 2018 Aug; 6(15):308. PubMed ID: 30211196
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Joint analysis of current status and marker data: an extension of a bivariate threshold model.
    Tong X; He X; Sun J; Lee ML
    Int J Biostat; 2008 Oct; 4(1):Article 21. PubMed ID: 20231913
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Measures to summarize and compare the predictive capacity of markers.
    Gu W; Pepe M
    Int J Biostat; 2009 Oct; 5(1):Article 27. PubMed ID: 20224632
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Statistical challenges in the development and evaluation of marker-based clinical tests.
    McShane LM
    BMC Med; 2012 May; 10():52. PubMed ID: 22642713
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Estimating improvement in prediction with matched case-control designs.
    Bansal A; Pepe MS
    Lifetime Data Anal; 2013 Apr; 19(2):170-201. PubMed ID: 23358916
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Traditional statistical methods for evaluating prediction models are uninformative as to clinical value: towards a decision analytic framework.
    Vickers AJ; Cronin AM
    Semin Oncol; 2010 Feb; 37(1):31-8. PubMed ID: 20172362
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Is My Clinical Prediction Model Clinically Useful? A Primer on Decision Curve Analysis.
    Mijderwijk HJ; Nieboer D
    Acta Neurochir Suppl; 2022; 134():115-118. PubMed ID: 34862535
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Combined benefit of prediction and treatment: a criterion for evaluating clinical prediction models.
    Billheimer D; Gerner EW; McLaren CE; LaFleur B
    Cancer Inform; 2014; 13(Suppl 2):93-103. PubMed ID: 25336898
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Editorial for the special issue of "Statistical Methods in Medical Research" on "Advanced ROC analysis".
    Nakas CT; Reiser B
    Stat Methods Med Res; 2018 Mar; 27(3):649-650. PubMed ID: 29187064
    [No Abstract]   [Full Text] [Related]  

  • 58. Deciding with Thresholds: Importance Measures and Value of Information.
    Borgonovo E; Cillo A
    Risk Anal; 2017 Oct; 37(10):1828-1848. PubMed ID: 28095589
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Simple Methods for Evaluating 4 Types of Biomarkers: Surrogate Endpoint, Prognostic, Predictive, and Cancer Screening.
    Baker SG; Kramer BS
    Biomark Insights; 2020; 15():1177271920946715. PubMed ID: 32821082
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Decision analysis for the evaluation of diagnostic tests, prediction models and molecular markers.
    Vickers AJ
    Am Stat; 2008; 62(4):314-320. PubMed ID: 19132141
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.